SMLR News and Press, Semler Scientific Inc From 04/07/22

Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference PR Newswire SANTA CLARA, Calif. , April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical eff...

Semler Scientific (NASDAQ:SMLR) has announced a $20M stock buyback program. The program has no expiration date. Earlier this month, Semler Scientific plunged after first recording quarterly contraction in over a year For further details see: Semler Scientific announces $20M stock buybac...

Semler Scientific's Board of Directors authorizes an up to $20.0 million stock repurchase program PR Newswire SANTA CLARA, Calif. , March 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to impr...

A shift in Variable Fee purchasing behavior post-Covid contributed to revenue contraction in Q4. Despite muted quarter, Semler had a strong year as it recovered from Covid impact, growing revenue 37% and EPS 22%. Semler has a large market opportunity and a recent peer-reviewed stu...

Gainers: Avenue Therapeutics (NASDAQ:ATXI) +165%. CTI BioPharma (NASDAQ:CTIC) +60%. UserTesting (NYSE:USER) +31%. Oak Street Health (NYSE:OSH) +25%. iQIYI (NASDAQ:IQ) +24%. Veritiv (NYSE:VRTV) +18%. TaskUs (NASDAQ:TASK) +17%. Danimer Scientific (NYSE:DNMR) +17%. LivePerson (NASDAQ:LPSN) +16%....

Semler Scientific (SMLR -27.4%) has shed over a fifth on Tuesday to record the biggest intraday loss in nearly four months after the healthcare equipment maker reported worse than expected results for Q4 2021. Marking the first revenue contraction in five quarters, the Q4 2021 revenue fe...

Gainers: CTI BioPharma (NASDAQ:CTIC) +40%. Oak Street Health (NYSE:OSH) +23%. AVITA Medical (NASDAQ:RCEL) +15%. Axsome Therapeutics (NASDAQ:AXSM) +14%. Protagonist Therapeutics (NASDAQ:PTGX) +12%. Losers: GoodRx Holdings (NASDAQ:GDRX) -40%. Semler Scientific...

Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery Results show a positive screening of previously undetected PAD was independently associated with short-term and long-term increased risks for mortality and major adverse cardiovascular ev...

Semler Scientific, Inc. (SMLR) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - Chief Executive Officer Dennis Rosenberg - Chief Marketing Officer Andrew Weinstein - Senior Vice President, Finance and Accounting Conference Call Part...

Semler Scientific press release (NASDAQ:SMLR): Q4 Non-GAAP EPS of $0.33 misses by $0.08. Revenue of $11.5M (-5.0% Y/Y) misses by $1.55M. Shares -11%. Semler Scientific will host a conference call on Monday at 4:30 p.m. ET. to address results as well as provide a business update on its ma...